Company Profile
A Vancouver-based clinical-stage biotech designing next-generation serotonin-targeting drugs for serious psychiatric disorders — aiming to deliver psychedelic-like therapeutic benefits without the hallucinogenic experience.
- 🧪 Precision serotonin agonists designed to achieve therapeutic efficacy without causing full hallucinogenic effects